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Mammalian cell culture is used for the production of pro-
teins for numerous therapeutics, diagnostics, vaccines,
and the generation of cells used in biomedical devices.
During cell culture, the cells are exposed to numerous
external and internal insults such as nutrient depletion,
toxin accumulation, viral infections, and external shear
stress. These events can sometimes cause the cells to trig-
ger a biochemical cascade called apoptosis or pro-
grammed cell death in which the cells actively participate
in their own demise. The programmed cell death (PCD)
cascade decreases the number of viable cells in a bioreac-
tor and leads to the premature termination of cell culture
runs. Cell death may also lower productivity since biore-
actor resources must be utilized to replace dead or dying
cells. As a result, methodologies that limit the activation
of this cascade are desirable and represent one of the most
significant applications of metabolic engineering in cell
culture. In this way, it may be possible to extend mamma-
lian cell lifetimes and function for multiple biotechnology
and bioengineering applications. The engineering of pro-
duction cell lines to express anti-apoptotic genes may
have numerous potential process benefits, including
enhanced cell survival, increased protein expression and
improved product quality. A number of natural anti-
apoptosis genes have been identified in both eucaryotes
and viruses and these anti-apoptosis proteins are being
used to block or limit the cell death cascade. Unfortu-
nately, these anti-apoptosis proteins can be degraded in
culture or otherwise eliminated. In order to increase their
activity, some of the anti-apoptosis proteins can be mod-
ified to limit degradation in cell systems. In addition,
apoptosis pathways include feedback and feedforward
loops that lead to amplification of the apoptotic response.
Strategies that block cell death at multiple points along
the cascade may limit the amplification of these apoptotic
signals. As a result, the expression of multiple anti-apop-
tosis genes has been explored in order to extend cell sur-
vival and improve protein production. More recently, the
role of bioprocess environments is being examined by
investigating survival of cells engineered to include anti-
apoptosis genes in different bioreactors with various oper-
ating conditions. The use of different bioreactors allows
cell culture engineers to examine the relationship between
anti-apoptosis engineering and cell physiology and pro-
ductivity for mammalian cell systems.
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